HomeComparePKBO vs FCPT

PKBO vs FCPT: Dividend Comparison 2026

PKBO yields 8888.89% · FCPT yields 6.05%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PKBO wins by $17290949737713800.00M in total portfolio value
10 years
PKBO
PKBO
● Live price
8888.89%
Share price
$0.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$17290949737713800.00M
Annual income
$16,916,578,202,775,594,000,000.00
Full PKBO calculator →
FCPT
FCPT
● Live price
6.05%
Share price
$23.65
Annual div
$1.43
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.1K
Annual income
$5,775.28
Full FCPT calculator →

Portfolio growth — PKBO vs FCPT

📍 PKBO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPKBOFCPT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PKBO + FCPT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PKBO pays
FCPT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PKBO
Annual income on $10K today (after 15% tax)
$755,555.56/yr
After 10yr DRIP, annual income (after tax)
$14,379,091,472,359,256,000,000.00/yr
FCPT
Annual income on $10K today (after 15% tax)
$514.49/yr
After 10yr DRIP, annual income (after tax)
$4,908.99/yr
At 15% tax rate, PKBO beats the other by $14,379,091,472,359,256,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PKBO + FCPT for your $10,000?

PKBO: 50%FCPT: 50%
100% FCPT50/50100% PKBO
Portfolio after 10yr
$8645474868856900.00M
Annual income
$8,458,289,101,387,797,000,000.00/yr
Blended yield
97.83%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on FCPT right now

PKBO
No analyst data
Altman Z
13837.7
Piotroski
4/9
FCPT
Analyst Ratings
5
Buy
10
Hold
Consensus: Hold
Price Target
$27.00
+14.2% upside vs current
Range: $25.00 — $29.00
Altman Z
1.4
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PKBO buys
0
FCPT buys
0
No recent congressional trades found for PKBO or FCPT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPKBOFCPT
Forward yield8888.89%6.05%
Annual dividend / share$2.00$1.43
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8%
Portfolio after 10y$17290949737713800.00M$49.1K
Annual income after 10y$16,916,578,202,775,594,000,000.00$5,775.28
Total dividends collected$17265985963886318.00M$24.1K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: PKBO vs FCPT ($10,000, DRIP)

YearPKBO PortfolioPKBO Income/yrFCPT PortfolioFCPT Income/yrGap
1← crossover$899,589$888,888.89$11,401$700.92+$888.2KPKBO
2$75,694,763$74,732,202.61$13,064$864.84+$75.68MPKBO
3$5,957,858,933$5,876,865,536.53$15,051$1,072.48+$5957.84MPKBO
4$438,676,028,838$432,301,119,780.33$17,442$1,337.22+$438676.01MPKBO
5$30,217,280,421,144$29,747,897,070,286.80$20,340$1,677.08+$30217280.40MPKBO
6$1,947,399,451,993,550$1,915,066,961,942,926.00$23,880$2,116.57+$1947399451.97MPKBO
7$117,429,004,658,116,600$115,345,287,244,483,520.00$28,241$2,689.36+$117429004658.09MPKBO
8$6,625,994,131,926,989,000$6,500,345,096,942,805,000.00$33,660$3,442.07+$6625994131926.96MPKBO
9$349,879,939,194,586,330,000$342,790,125,473,424,500,000.00$40,456$4,439.95+$349879939194586.25MPKBO
10$17,290,949,737,713,800,000,000$16,916,578,202,775,594,000,000.00$49,063$5,775.28+$17290949737713800.00MPKBO

PKBO vs FCPT: Complete Analysis 2026

PKBOStock

Peak Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics addressing unmet needs in the areas of oncology and inflammation. The company's proprietary toxin, PH-1 or Thailanstatin, a spliceosome modulator is being used to generate its first pipeline of novel ADC product candidates to address unmet needs in cancer patients. Its lead product candidate, PHP-303, is a small molecule awaiting Phase II dose clinical study in the orphan disease Alpha1 anti-trypsin deficiency (AATD). The company is based in Palo Alto, California.

Full PKBO Calculator →

FCPTREIT

FCPT, headquartered in Mill Valley, CA, is a real estate investment trust primarily engaged in the acquisition and leasing of restaurant properties. The Company seeks to grow its portfolio by acquiring additional real estate to lease, on a net basis, for use in the restaurant and retail industries.

Full FCPT Calculator →
📬

Get this PKBO vs FCPT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PKBO vs SCHDPKBO vs JEPIPKBO vs OPKBO vs KOPKBO vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.